Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers
Toxicological Sciences · 2023
DOI: 10.1093/toxsci/kfad075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2023. Verfasst von Zachary Clemens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Arsenic, Muscular Diseases, Extracellular Vesicles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIEHS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Chronic exposure to environmental arsenic is a public health crisis affecting hundreds of millions of individuals worldwide. Though arsenic is known to contribute to many pathologies and diseases, including cancers, cardiovascular and pulmonary diseases, and neurological impairment, the mechanisms for arsenic-promoted disease remain unresolved. This is especially true for arsenic impacts on skeletal muscle function and metabolism, despite the crucial role that skeletal muscle health plays in maintaining cardiovascular health, systemic homeostasis, and cognition. A barrier to researching this area is the challenge of interrogating muscle cell-specific effects in biologically relevant models. Ex vivo studies investigating mechanisms for muscle-specific responses to arsenic or other environmental contaminants primarily utilize traditional 2-dimensional culture models that cannot elucidate effects on muscle physiology or function. Therefore, we developed a contractile 3-dimensional muscle construct model—composed of primary mouse muscle progenitor cells differentiated in a hydrogel matrix—to study arsenic exposure impacts on skeletal muscle regeneration. Muscle constructs exposed to low-dose (50 nM) arsenic exhibited reduced strength and myofiber diameter following recovery from muscle injury. These effects were attributable to dysfunctional paracrine signaling mediated by extracellular vesicles (EVs) released from muscle cells. Specifically, we found that EVs collected from arsenic-exposed muscle constructs recapitulated the inhibitory effects of direct arsenic exposure on myofiber regeneration. In addition, muscle constructs treated with EVs isolated from muscles of arsenic-exposed mice displayed significantly decreased strength. Our findings highlight a novel model for muscle toxicity research and uncover a mechanism of arsenic-induced muscle dysfunction by the disruption of EV-mediated intercellular communication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
- Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute at Spaulding, Boston, Massachusetts, USA.
- Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Zachary Clemens, Aaron Barchowsky
Förderung
- NIA NIH HHS
- NIEHS NIH HHS
- NIH HHS
- National Institute of Environmental Health Sciences
- National Institute on Aging
- National Institutes of Health
- Center for Biologic Imaging
Zitieren
APA
Clemens, Z., Wang, K., Ambrosio, F., & Barchowsky, A. (2023). Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfad075
Vancouver
Clemens Z, Wang K, Ambrosio F, Barchowsky A. Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers. Toxicological Sciences. 2023. doi:10.1093/toxsci/kfad075
BibTeX
@article{Clemens2023,
author = {Clemens, Zachary and Wang, Kai and Ambrosio, Fabrisia and Barchowsky, Aaron},
title = {Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers},
journal = {Toxicological Sciences},
year = {2023},
doi = {10.1093/toxsci/kfad075}
}
EUVIMED